Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates.
-
d'Orchymont F
Department of Chemistry , University of Zurich , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland.
-
Hess J
Department of Chemistry , University of Zurich , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland.
-
Panic G
Department of Medical Parasitology and Infection Biology , Swiss Tropical and Public Health Institute , CH-4051 , Basel , Switzerland . Email: jennifer.keiser@unibas.ch.
-
Jakubaszek M
Laboratory for Inorganic Chemical Biology , Chimie ParisTech , PSL University , F-75005 Paris , France . Email: gilles.gasser@chimieparistech.psl.eu.
-
Gemperle L
Department of Chemistry , University of Zurich , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland.
-
Keiser J
Department of Medical Parasitology and Infection Biology , Swiss Tropical and Public Health Institute , CH-4051 , Basel , Switzerland . Email: jennifer.keiser@unibas.ch.
-
Gasser G
Laboratory for Inorganic Chemical Biology , Chimie ParisTech , PSL University , F-75005 Paris , France . Email: gilles.gasser@chimieparistech.psl.eu.
Show more…
English
We present the design, synthesis, characterization and biological evaluation of new ferrocenyl and ruthenocenyl derivatives of the organic antimalarial mefloquine, a drug also known for its antischistosomal activity. The two metallocenyl derivatives prepared (3 and 4) demonstrated comparable activity to mefloquine against adult-stage Schistosoma mansoni in vitro. Importantly, both compounds were found to have lower toxicity in all cell lines than mefloquine itself. Administration of a 200 mg kg-1 oral dose of 3 and 4 to S. mansoni-infected mice did not significantly reduce worm burden, contrary to mefloquine.
-
Language
-
-
Open access status
-
green
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/127260
Statistics
Document views: 12
File downloads: